Baird Medical Investment Holdings Limited (BDMD) vs MDxHealth S.A. (MDXH)

A side-by-side comparison of Baird Medical Investment Holdings Limited and MDxHealth S.A. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BDMD vs MDXH

growth of $100 · dividends reinvested · last 5y
BDMD -92.3% (-40.1%/yr)MDXH -93.2% (-41.6%/yr)BDMD compounded faster over this window
050100Start $10020222023202420252026$8$7
BDMD MDXH

BDMD vs MDXH: by the numbers

  • •BDMD is the larger company ($33M vs $31M market cap).
  • •Both run net losses; MDXH's is the smaller (-31.07% vs -121.04% net margin).
  • •MDXH grew revenue faster over the past five years (42.35% vs 4.46% CAGR).

Metrics side by side

Valuation

MetricBDMDMDXH
Forward P/E9.75N/A
P/B ratio0.95N/A

Profitability

MetricBDMDMDXH
Gross margin83.79%59.74%
Operating margin-113.31%-14.28%
Net margin-121.04%-31.07%
ROE-86.96%N/A
ROIC-50.66%-15.35%

Growth (annualized)

MetricBDMDMDXH
Revenue CAGR (5Y)4.46%42.35%

Frequently asked

Which has grown faster, BDMD or MDXH?
Over the past five years, MDXH grew revenue faster — BDMD at a 4.46% CAGR versus MDXH at 42.35%.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.